Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

Patients with severe eosinophilic asthma experience daily activity limitations and reduced productivity at work. Using anonymized individual patient‐level data from two previously conducted randomized, double‐blind, placebo‐controlled studies (MENSA [GSK ID:115588/NCT01691521]; MUSCA [GSK ID:200862/...

Descripción completa

Detalles Bibliográficos
Autores principales: Albers, Frank C., Bratton, Daniel J., Gunsoy, Necdet B., Cockle, Sarah M., Alfonso‐Cristancho, Rafael, Braunstahl, Gert‐Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060075/
https://www.ncbi.nlm.nih.gov/pubmed/35081275
http://dx.doi.org/10.1111/crj.13474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060075/
https://www.ncbi.nlm.nih.gov/pubmed/35081275
http://dx.doi.org/10.1111/crj.13474

Ejemplares similares